Clinical Trial Update: The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for the immunogenicity and safety of a live attenuated poliomyelitis vaccine (Human Diploid Cell) addressing poliomyelitis, completed phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Live attenuated poliomyelitis vaccine (Human Diploid Cell)

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: Poliomyelitis | Phase 2, Phase 3 | Status: COMPLETED